Journal of Antimicrobial Chemotherapy · 1987 · 15 citations · 0 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceMedical MicrobiologyMicrobial PathogenesisAntibiotic ResistanceAntimicrobial Susceptibility TestingTuberculosis Diagnostic TestingAntimycobacterial Agent SelectionDrug Resistance TestingMycobacterium Tuberculosis InfectionPhenotypic Drug Susceptibility TestingPhenotypic Susceptibility ProfilingTuberculosis Drug Resistance
Various clinical isolates of mycobacteria were tested for susceptibility to ciprofloxacin by a standard macrobroth dilution test and the radiometric BACTEC method. Agreement between the two test systems was species dependent: Mycobacterium tuberculosis (80%), M. kansasii with M. scrofulaceum (30%), M. avium-intracellulare (20%), and 0% for the rapidly growing mycobacteria. Most mycobacterial strains other than M. tuberculosis were susceptible to the breakpoint ciprofloxacin concentration of 2 mg/l as determined by BACTEC MICs, whereas none were susceptible by macrobroth testing. Seven of nine M. tuberculosis isolates were susceptible by either method. Ciprofloxacin merits further study as a potential antimycobacterial agent.